[1]
S. Safaie, H. Mir Mohammad Sadeghi, and Z. Mir Mohammad Sadeghi, “Association of insertion/deletion mutations in angiotensin converting enzyme (ACE) gene and effectiveness of Glibenclamide therapy in Iranian type 2 diabetic patients”, Int Pharm Acta, vol. 1, no. 1, pp. 75–75, Mar. 2018.